Lianjun Xing

434 total citations
23 papers, 357 citations indexed

About

Lianjun Xing is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Lianjun Xing has authored 23 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 9 papers in Molecular Biology and 7 papers in Hepatology. Recurrent topics in Lianjun Xing's work include Liver Disease Diagnosis and Treatment (15 papers), Liver physiology and pathology (4 papers) and Lipid metabolism and disorders (4 papers). Lianjun Xing is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Liver physiology and pathology (4 papers) and Lipid metabolism and disorders (4 papers). Lianjun Xing collaborates with scholars based in China and France. Lianjun Xing's co-authors include Guang Ji, Peiyong Zheng, Li Zhang, Tao Liu, Yongqiang Hua, Tao Wu, Mingyuan Wu, Lili Yang, Wenjun Zhou and Yanqi Dang and has published in prestigious journals such as European Journal of Pharmacology, World Journal of Gastroenterology and Chemical Research in Toxicology.

In The Last Decade

Lianjun Xing

20 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lianjun Xing China 12 154 142 75 70 53 23 357
Shengliang Xin China 9 239 1.6× 164 1.2× 64 0.9× 37 0.5× 49 0.9× 12 409
Nengzhi Pang China 11 230 1.5× 200 1.4× 91 1.2× 68 1.0× 24 0.5× 20 541
Sha Hu China 8 179 1.2× 175 1.2× 54 0.7× 46 0.7× 23 0.4× 12 354
Yuan-ye Qiu China 10 115 0.7× 257 1.8× 101 1.3× 87 1.2× 62 1.2× 13 535
Xiaoyan Qiang China 6 188 1.2× 194 1.4× 53 0.7× 98 1.4× 93 1.8× 9 480
Wen Shan China 10 205 1.3× 229 1.6× 63 0.8× 21 0.3× 50 0.9× 13 508
Yujia Zhou China 9 130 0.8× 119 0.8× 66 0.9× 63 0.9× 15 0.3× 21 340
Lingxi Kong China 6 76 0.5× 109 0.8× 101 1.3× 28 0.4× 39 0.7× 15 384
Fuyuan Yang China 6 149 1.0× 155 1.1× 62 0.8× 18 0.3× 48 0.9× 10 343
Jianzhi Wu China 15 200 1.3× 195 1.4× 28 0.4× 24 0.3× 90 1.7× 25 483

Countries citing papers authored by Lianjun Xing

Since Specialization
Citations

This map shows the geographic impact of Lianjun Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianjun Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianjun Xing more than expected).

Fields of papers citing papers by Lianjun Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianjun Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianjun Xing. The network helps show where Lianjun Xing may publish in the future.

Co-authorship network of co-authors of Lianjun Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Lianjun Xing. A scholar is included among the top collaborators of Lianjun Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianjun Xing. Lianjun Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Xiao, D. X., et al.. (2024). Chronic atrophic gastritis and risk of incident upper gastrointestinal cancers: a systematic review and meta-analysis. Journal of Translational Medicine. 22(1). 429–429. 17 indexed citations
4.
5.
Tang, Ling, et al.. (2023). Qinggan Huoxue Recipe Protects against Experimental Alcoholic Liver Fibrosis through CXCL16 Inhibition. Evidence-based Complementary and Alternative Medicine. 2023(1). 5642713–5642713. 1 indexed citations
6.
Shen, Nan, Lin Tang, Hongyu Miao, et al.. (2023). Serum miR-4488 as a potential biomarker of lean nonalcoholic fatty liver disease. Annals of Translational Medicine. 11(4). 173–173. 13 indexed citations
7.
Zhou, Wenjun, et al.. (2022). Natural PPARs agonists for the treatment of nonalcoholic fatty liver disease. Biomedicine & Pharmacotherapy. 151. 113127–113127. 34 indexed citations
8.
Shen, Nan, et al.. (2021). Fibrates for the treatment of pruritus in primary biliary cholangitis: a systematic review and meta-analysis. Annals of Palliative Medicine. 10(7). 7697–7705. 13 indexed citations
9.
Fan, Shengjie, Haiyan Zhang, Ya‐Hui Wang, et al.. (2021). LXRα/β Antagonism Protects against Lipid Accumulation in the Liver but Increases Plasma Cholesterol in Rhesus Macaques. Chemical Research in Toxicology. 34(3). 833–838. 7 indexed citations
10.
Zhang, Haiyan, Lu Zou, Ling Tang, et al.. (2021). Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis. Pharmaceutical Biology. 59(1). 1357–1366. 5 indexed citations
11.
Zou, Lu, et al.. (2021). Preparation and evaluation of Bergenin-loaded cationic liposome for anti-asthma treatment. Materials Express. 11(5). 601–617. 2 indexed citations
12.
Wu, Mingyuan, et al.. (2020). Circ_0004913 Inhibits Cell Growth, Metastasis, and Glycolysis by Absorbing miR-184 to Regulate HAMP in Hepatocellular Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 38(10). 708–719. 26 indexed citations
13.
Wu, Tao, Tao Liu, Lianjun Xing, & Guang Ji. (2018). Baicalin and puerarin reverse epithelial‑mesenchymal transition via the TGF‑β1/Smad3 pathway in�vitro. Experimental and Therapeutic Medicine. 16(3). 1968–1974. 21 indexed citations
14.
Wu, Tao, Junming Chen, Hanchen Xu, et al.. (2016). Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway. World Journal of Gastroenterology. 22(19). 4695–4695. 28 indexed citations
15.
16.
17.
Chen, Junming, et al.. (2013). Role of matrix metalloproteinases and tissue inhibitor of metalloproteinases type-1 in the development of alcoholic liver fibrosis in rats. World Chinese Journal of Digestology. 21(17). 1595–1595. 1 indexed citations
18.
Xing, Lianjun, Li Zhang, Tao Liu, et al.. (2011). Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver. European Journal of Pharmacology. 668(3). 467–471. 74 indexed citations
19.
Chen, Junming, Lei Wang, & Lianjun Xing. (2011). [Regulatory effects of Qinggan Huoxue Recipe on matrix metalloproteinases of alcoholic liver fibrosis rats].. PubMed. 31(11). 1538–44. 3 indexed citations
20.
Zheng, Peiyong, et al.. (2009). Effect of Jiangzhi granule on STAT3 expression in hypothalamus of rats with nonalcoholic fatty liver disease. World Chinese Journal of Digestology. 17(8). 753–753. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shengliang Xin Breakdown of academic impact, for papers by Nengzhi Pang Breakdown of academic impact, for papers by Sha Hu Breakdown of academic impact, for papers by Yuan-ye Qiu Breakdown of academic impact, for papers by Xiaoyan Qiang Breakdown of academic impact, for papers by Wen Shan Breakdown of academic impact, for papers by Yujia Zhou Breakdown of academic impact, for papers by Lingxi Kong Breakdown of academic impact, for papers by Fuyuan Yang Breakdown of academic impact, for papers by Jianzhi Wu
Rankless by CCL
2026